COMMUNIQUÉS West-GlobeNewswire

ThromboGenics Enrolls First Patient in Phase 1 Clinical Study Evaluating THR-149, a plasma kallikrein inhibitor, for treatment of Diabetic Macular Edema (DME)
25/05/2018
Press release Leuven, Belgium, 25 May 2018 - ThromboGenics NV (Euronext Brussels: THR), a biotechnology company developing novel medicines for diabetic eye disease, announces that it has successfully enrolled the first [...]
Extendicare Announces Voting Results from the 2018 Annual and Special Meeting of Shareholders and Board Change
25/05/2018
MARKHAM, Ontario, May 24, 2018 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE ) today announced the results of matters voted on at its annual and special shareholders’ meeting held on [...]
Burcon Announces Intention to File Form 25
24/05/2018
VANCOUVER, British Columbia, May 24, 2018 (GLOBE NEWSWIRE) -- Burcon NutraScience Corporation (TSX: BU ) (NASDAQ: BUR ) (“Burcon” or the “Company”), a leader in natural product extraction, purification and isolation [...]
Hydropothecary Announces Acceleration of Warrant Expiry Date
24/05/2018
GATINEAU, Quebec, May 24, 2018 (GLOBE NEWSWIRE) -- The Hydropothecary Corporation (“THCX” or the “Company”) (TSX-V: THCX ) announced today that it has elected to exercise its right under the warrant indenture (the “ [...]
Hydropothecary annonce le devancement de l'échéance de bons de souscription
24/05/2018
GATINEAU, Québec, 24 mai 2018 (GLOBE NEWSWIRE) -- La société Hydropothecary (" THCX " ou la " Société ") (TSX CROISSANCE:THCX) a annoncé aujourd'hui qu'elle a choisi d'exercer son droit en vertu de l'acte de fiducie (l [...]
Amarin Announces Patent Litigation Settlement Agreement with Teva
24/05/2018
BEDMINSTER, N.J. and DUBLIN, Ireland, May 24, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve [...]
Retrophin to Present at Upcoming Investor Conferences
24/05/2018
SAN DIEGO, May 24, 2018 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX ) today announced that the Company’s management team will present at the following upcoming investor conferences in June: Jefferies 2018 Global [...]
Kane Biotech to Present at TakeStock! Investor Forum
24/05/2018
Forum Held May 31 in Association with TSX Venture Exchange WINNIPEG, Manitoba, May 24, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V: KNE ) (OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”) is pleased to announce [...]
ContraVir Pharmaceuticals, Inc. Announces Reverse Stock Split
24/05/2018
EDISON, N.J., May 24, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), a biopharmaceutical company focused on the development and commercialization of therapeutic drugs for the treatment of [...]
Ogilvy CommonHealth Worldwide’s Johanna Skilling and Jennifer Werther to be honored at MM&M’s 2018 Hall of Femme ceremony
24/05/2018
PARSIPPANY, N.J., May 24, 2018 (GLOBE NEWSWIRE) -- Ogilvy CommonHealth Worldwide ( www.ogilvychww.com ), a WPP Health & Wellness company (NYSE: WPP ) ( www.wpp.com ), today announced Johanna Skilling, head of [...]
I-MED Pharma to Bring Clinically Proven E>Eye IRPL® Technology to Canada
24/05/2018
MONTREAL, May 24, 2018 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the signing of a Canadian distribution agreement with ESW Vision [...]
I-MED Pharma présente la technologie éprouvée E>Eye IRPL® au Canada
24/05/2018
MONTRÉAL, 24 mai 2018 (GLOBE NEWSWIRE) -- I-MED Pharma inc., une entreprise canadienne spécialisée dans le diagnostic et la prise en charge de la sécheresse oculaire, est ravie d’annoncer l’officialisation d’une entente [...]
Announcement from Xbrane Biopharma's annual general meeting
24/05/2018
Press release 2018-05-24 The annual general meeting (" AGM ") of Xbrane Biopharma AB (" Xbrane " or the " Company ") was held today on 24 May 2018 and the following resolutions were passed by the meeting. Adoption of [...]
BioCryst's BCX7353 Receives European Regulatory Designations for the Treatment of Hereditary Angioedema
24/05/2018
EMA Grants Orphan Designation UK MHRA Grants Promising Innovative Medicine Designation RESEARCH TRIANGLE PARK, N.C., May 24, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX ), a pharmaceutical [...]
BIOPHYTIS: Inclusion of the First Patient in Phase 2b Study in Sarcopenia
24/05/2018
Preliminary results expected in Q3 2019 PARIS, May 24, 2018 (GLOBE NEWSWIRE) -- BIOPHYTIS (Euronext Growth Paris: ALBPS), a biotechnology company specializing in the development of drug candidates to fight age-related [...]
Bulletin from the Annual Shareholders’ Meeting on May 24, 2018 in Saniona AB (Publ)
24/05/2018
PRESS RELEASE May 24, 2018 Today, on May 24, 2018, an annual shareholders’ meeting was held in Saniona AB (publ). A summary of the resolutions adopted follows below. All resolutions were adopted with the required [...]
Initial Clinical Results of Konica Minolta Healthcare’s Dynamic Digital Radiography Presented at ATS 2018 Annual Meeting
24/05/2018
WAYNE, N.J., May 24, 2018 (GLOBE NEWSWIRE) -- Konica Minolta Healthcare Americas, Inc., announced that two clinical studies utilizing Dynamic Digital Radiography (DDR), the company’s innovative X-ray technology under [...]
Genmab Announces Topline Results in Phase III study of Arzerra® in Indolent Non-Hodgkin’s Lymphoma
24/05/2018
Company Announcement Topline results from Phase III study in iNHL did not meet primary endpoint of improved progression-free survival Copenhagen, Denmark; May 24, 2018 – Genmab A/S (Nasdaq Copenhagen: GEN) announced [...]
Tabula Rasa HealthCare to Participate in Upcoming Investor Conferences
24/05/2018
MOORESTOWN, N.J., May 24, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: TRHC ), a healthcare technology company optimizing medication safety by deploying new, medication risk mitigation [...]

Pages